Intelligence · Clinical pipeline
Phase I Pipeline Programs
First-in-human and early clinical safety studies in Phase I.
Quick answer
NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.
Top sponsors
- BRIGHT MINDS BIOSCIENCES 327 programs
- Takeda 276 programs
- Anaxis Pharma 204 programs
- Chinese Academy of 190 programs
- United Therapeutics Europe 184 programs
- Teva Pharma 154 programs
- First People's Hospital 149 programs
- Regeneron UK 126 programs
- Boehringer Ingelheim 94 programs
- Sunshine Guojian Pharmaceutical 85 programs
- Lakefront Biotherapeutics NV 62 programs
- HOFFMANN-LA ROCHE 58 programs
Pipeline programs
-
Gonadorelin
BRIGHT MINDS BIOSCIENCES INC.
Cocaine-Related Disorders
1 trial -
Gonadotrophin releasing hormone agonist(GnRHa)
NORTHWEST BIOTHERAPEUTICS INC
GnRHa;LPS
1 trial -
Granisetron hydrochloride 1 mg tablets
Teva Pharma GmbH
Healthy
2 trials -
Granulocyte Colony-Stimulating Factor
United Therapeutics Europe Ltd
Biliary Atresia
1 trial -
Group 1: 10 ug FMP012 with 2 ug GLA-SE
United Therapeutics Europe Ltd
Malaria
1 trial -
Group A
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colorectal Cancer
1 trial -
Group A
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatocellular Carcinoma
1 trial -
Group A Deactivated TENS with beeping sound (15-second interval)
United Therapeutics Europe Ltd
Healthy
1 trial -
Guadecitabine
United Therapeutics Europe Ltd
Non Small Cell Lung Cancer
1 trial -
H5.001CBCFTR
Ultragenyx UK Limited
Cystic Fibrosis
1 trial -
HB0017
Huabo Biopharm Co.,
Healthy Subjects
1 trial -
HB0056
Shanghai University of Traditional Chinese Medicine
Healthy
1 trial -
HBS-201
Harmony Biosciences Holdings
Narcolepsy
1 trial -
HBT-708
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Advanced Solid Tumors
1 trial -
HBV mRNA vaccine
Hospital Authority, Hong Kong
Hepatocellular Carcinoma (HCC)
1 trial -
HBV mRNA vaccine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Liver Cancer
1 trial -
HD204
Prestige Biopharma Belgium
Healthy Volunteers
1 trial -
HDP-102-01
Lacuna Pharma Pty Ltd
Relapsed/Refractory B-cell Malignancies
1 trial -
HEC 68498
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Idiopathic Pulmonary Fibrosis
1 trial -
HEC-007 injection
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Healthy Subjects
1 trial -
HEC-151 Injection
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Healthy Adult Male
1 trial -
HEC113995
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Major Depressive Disorder
1 trial -
HEC113995 PA•H2O tablets
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Major Depressive Disorder
1 trial -
HEC113995PA•H2O tablet
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Healthy
1 trial -
HEC116094
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Influenza
1 trial -
HEC122505MsOH
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Parkinson Disease
1 trial -
HEC169584 capsule
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Non - Alcoholic Steatohepatitis
1 trial -
HEC30654AcOH capsule
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Healthy
1 trial -
HEC53856
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Hemodialysis
1 trial -
HEC53856
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Healthy
1 trial -
HEC53856
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Chronic Kidney Diseases
1 trial -
HEC68498
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Advanced Refractory Solid Tumors
1 trial -
HEC73077 tablets
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Diabetic Nephropathy
1 trial -
HEC74647
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Chronic Hepatitis C
1 trial -
HEC74647PA capsule
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Chronic Hepatitis C
2 trials -
HEC83518
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Insomnia
1 trial -
HEC83518 tablets
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Insomnia
1 trial -
HEC89736
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Relapsed or Refractory B-cell Hematologic Malignancies
1 trial -
HEC93077
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Gout
1 trial -
HEC96719
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Non-alcoholic Fatty Liver Disease
1 trial -
HEC96719
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Nonalcoholic Steatohepatitis (NASH)
1 trial -
HEC96719 tablets
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Nonalcoholic Steatohepatitis (NASH)
1 trial -
HER-2/neu peptide vaccine
Marker Therapeutics
HER2-positive Breast Cancer
1 trial -
HER2 Tumor Vaccine
The First People's Hospital of Lianyungang
Adenocarcinoma - GEJ
1 trial -
HER3-DXd
Daiichi Sankyo
Non-Small Cell Lung Cancer (NSCLC)
1 trial -
HIV-1 C4-V3 Polyvalent Peptide Vaccine
Praxis Precision Medicines
HIV Infections
1 trial -
HMPL-306
Hutchison Medipharma Limited
Acute Myeloid Leukemia
1 trial -
HMS5552
Hua Medicine Limited
Type II Diabetes Mellitus
1 trial
Frequently asked questions
How many Phase I pipeline programs are in the directory?
4,713 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.